Dr. Joe was interviewed by Disruption Magazine about longevity and machine learning! Page 23

January 7, 2019


Here one can access our Whitepaper which reviews the state of drug development and how NetraMark is providing next generation machine learning methods to disrupt this industry. We review patient stratification, deep phenotyping, drug repositioning, and placebo response and how we are addressing these challenges.